How a referral-grown healthcare software firm opened a cold channel to C-level founders in three countries.

The client builds compliance-ready software for healthcare. Its buyers are founders, its pain is regulatory, and its growth had come entirely through referral. We mapped its market into three ICP segments and proved the compliance-first message carries cold.

LinkedIn outbound · US · Australia · UK · C-level healthcare

• ~1,870 prospects mapped

• 3 ICP segments, client-approved

• 16.5% reply rate

• 28.6% conversation-to-opportunity

• 4 qualified opportunities

At a glance

• Client: Healthcare software developer

• Sector: Healthcare software: HIPAA-aware builds, SaMD, EMR/EHR integration, generative AI

• Footprint: 50 to 100 staff · two Indian development centres · offices in California and New South Wales · clients in 10+ countries

• Market: United States · Australia · United Kingdom

• ICP: C-level (Owner, CEO, Founder, Co-founder, CTO) at healthcare, healthtech, medical-device and SaMD companies under 100 employees

• Deal profile: $50,000 average engagement · 1 to 3 month sales cycle

• Engagement: April to May 2026 · about six weeks

• Channel: LinkedIn outbound

• Services: ICP segmentation · List building · LinkedIn outreach · Qualification

Result

What six weeks built.

• 4 qualified opportunities with C-level decision-makers, all in live conversation at close, in a market where the client's average engagement is $50,000.

• 16.5% reply rate among contacts who connected, from a founder-level audience choosing to engage.

• 28.6% conversation-to-opportunity conversion: better than one in four live conversations became a real deal.

• ~1,870 prospects mapped across three client-approved ICP segments, roughly half still unworked.

A sharp pitch with a ceiling on it.

The client's positioning is narrower and more credible than most development firms manage. It works with founder-led healthcare teams who have no in-house technical leadership, and its value is compliance handled as an architecture decision rather than a retrofit after an investor asks a hard question or a pilot stalls. HIPAA, GDPR, PHI, FDA device classification, SaMD, IEC 62304: the vocabulary is earned, and the shipped case studies back it.

That reputation had driven growth almost entirely through referral and repeat clients. Which works, right up to the point you want to decide how much pipeline you get. The firm wanted a channel it controlled.

The hardest buyer in B2B software, in three timezones.

• The buyer is the founder. No procurement layer, no evaluation committee. One person running the company and owning the technical decision, with near-zero tolerance for a generic development pitch.

• The pain is regulatory, and it surfaces late. A founder becomes a buyer at a specific moment: an investor asks how HIPAA is handled, a developer admits no compliance experience, a previous vendor disappoints. Outside that moment, there is no conversation to have.

• Three segments, three reasons to buy. A diagnostic clinic fixing broken workflows, a B2C healthtech startup protecting patient data before a raise, and a provider-facing company facing a hospital integration deadline are not one audience.

Segment first. Then send.

• 01 Map the market by buying motivation. Three ICP segments built from how the client's buyers actually behave: healthcare small businesses with disconnected operational systems; B2C healthtech startups where patient data security decides whether a pilot survives; provider-facing healthtech carrying committed integration timelines. ~1,870 C-level contacts mapped across three geographies.

• 02 Get client sign-off before outreach. Every segment was submitted to the client for review before a single message went out, so messaging was built against buyers the client had confirmed were worth their team's time, not against a list an agency guessed at.

• 03 Lead with risk, not services. Messaging opened on the regulatory exposure a founder is already carrying, in the market's own vocabulary. That is the credibility test in healthcare software, and it is what separates a read message from a deleted one.

One channel, matched to the persona.

LinkedIn was the primary motion, the right call for founder-level buyers spread across three continents, where cold calling and cold email both carry timezone and trust penalties this audience applies quickly.

A thousand contacts were worked across roughly six weeks at controlled daily volume, to protect sending health over the full run rather than burning the account in a fortnight. Conversations were opened after connection rather than inside the request, so the first real message landed with a founder who had already chosen to accept.

Qualification ran three gates: connected, then a genuine two-way conversation, then a confirmed need specific enough to justify a scoped technical discussion. An accepted connection was never counted as an outcome.

Before and after

Before

• Growth dependent entirely on referral and repeat business

• No outbound channel, no mapped market, no segmentation of a market that buys for three different reasons

• No evidence the compliance-first message carried cold

After

• A controllable cold channel, built and running in six weeks

• ~1,870 C-level prospects mapped across 3 approved segments

• Message validated against founders who had never heard of the firm

• 4 qualified opportunities in live conversation

Quality of conversation, not volume of connection.

• Engagement. 14 live conversations at a 16.5% reply rate. Among contacts who connected, roughly one in six opened a genuine two-way conversation, from a founder-level audience that ignores vendor outreach by default.

• Conversion. 4 qualified opportunities, 28.6% of conversations. Better than one in four live conversations produced a real opportunity, each with a C-level decision-maker inside an approved segment.

• Market asset. ~870 prospects unworked. Half the approved audience is mapped, qualified and not yet touched: reach already paid for, available to the next phase with no new data spend.

What the numbers prove

A 16.5% reply rate and a 28.6% conversation-to-opportunity rate, from founders with no prior exposure to the firm, say the positioning travels. Compliance risk reduced before it becomes expensive rework is a message healthcare founders engage with when it reaches them in their own language, and at a $50,000 average engagement, a small number of the right conversations is what this market is built on.

Impact and key takeaways

Impact.

• A second, controllable channel alongside referral, built and proven in six weeks.

• 4 qualified opportunities with C-level buyers, carried forward live.

• Compliance-first positioning validated against a cold audience.

• A segmented, client-approved market map that outlasts the campaign.

Key takeaways.

• Segmentation before sending: three approved segments meant three messages that each matched a real buying motivation.

• Risk language beats service language with this persona.

• Treat an accepted connection as the start of qualification, not the end.

• A mapped market is an asset. Half of it is still runway.

Built for a specific buyer, not a generic funnel.

The market was segmented by why each buyer buys rather than by title alone, and signed off by the client before outreach began. The channel matched a founder-level audience across three continents. The messaging used the buyer's own regulatory vocabulary, which is the fastest credibility test in healthcare software. And every stage was tracked separately, so the campaign was judged on qualified opportunities rather than activity volume.

In summary

The client came in with a strong reputation, a hard ceiling on referral growth and no outbound channel. Six weeks later it had a mapped and approved market across three countries, a cold-validated message, four live opportunities with founder-level buyers, and roughly 870 qualified prospects still waiting.

The numbers

• ~1,870 Prospects mapped

• 3 Client-approved ICP segments

• 14 Live conversations

• 16.5% Reply rate

• 28.6% Conversation-to-opportunity

• 4 Qualified opportunities

• ~870 Prospects still unworked